Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

Several COVID-19 vaccines have shown good efficacy in clinical trials, but there remains uncertainty about the efficacy of vaccines against different variants. Here, we investigate the efficacy of ChAdOx1 nCoV-19 (AZD1222) against symptomatic COVID-19 in a post-hoc exploratory analysis of a Phase 3...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Clemens, SAC, Folegatti, PM, Emary, KRW, Weckx, LY, Ratcliff, J, Bibi, S, Verena De Almeida Mendes, A, Milan, EP, Pitella, A, Schwarzbold, AV, Sprinz, E, Aley, PK, Bonsall, D, Fraser, C, Fuskova, M, Gilbert, SC, Jenkin, D, Kelly, S, Kerridge, S, Lambe, T, Marchevsky, NG, Mujadidi, YF, Plested, E, Ramasamy, MN, Simmonds, P, Golubchik, T, Voysey, M, Pollard, AJ
अन्य लेखक:	AMPHEUS Project
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	Springer Nature 2021

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

समान संसाधन